These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Effect of semaphorin-3A on the cellular stability of CD4+CD25+ regulatory T cells induced by lipopolysaccharide].
    Author: Gao Y, Li L, Liu Y, Li W, Wang Z, Shou S, Chai Y.
    Journal: Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1454-1460. PubMed ID: 33541497.
    Abstract:
    OBJECTIVE: To investigate the effect and mechanism of semaphorin-3A (Sema3A) in maintaining the cellular stability of CD4+CD25+ regulatory T cells (Tregs) induced by lipopolysaccharide (LPS). METHODS: In vitro, using immunomagnetic beads, splenic CD4+CD25+ Tregs of C57BL/6J mice were isolated and cultured. According to the random number table, the isolated cells were divided into control group (treated with anti-CD3e and anti-CD28 for polyclonal activation), LPS group (on the basis of control group, treated with LPS at the dose of 100 μg/L), LPS + nuclear factor kappa B (NF-κB) inhibitor pyrrolidine dithiocarbamate (PDTC) group (treated with LPS at the dose of 100 μg/L and PDTC at the dose of 25 mg/L), LPS + phosphate buffer solution (PBS) group (treated with LPS at the dose of 100 μg/L and PBS at the volume of 10 μL), LPS + PDTC + recombinant Sema3A (rSema3A) group (treated with LPS at the dose of 100 μg/L, PDTC at the dose of 25 mg/L and rSema3A at the dose of 300 μg/L), and LPS + PBS + rSema3A group (treated with LPS at the dose of 100 μg/L, PBS at the volume of 10 μL and rSema3A at the dose of 300 μg/L). mRNA and protein expressions of the specific markers of CD4+CD25+ Tregs, including forkhead box protein P-3 (Foxp-3), cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) and membrane-associated transforming growth factor-β1 (TGF-β1m+) were detected by reverse transcription-polymerase chain reaction (RT-PCR) and immunofluorescence methods after 24 hours. The supernatant interleukin-10 (IL-10) and secretory type TGF-β1 (sTGF-β1) were detected by enzyme-linked immunosorbent assay (ELISA). The apoptotic level was detected by immunofluorescence. The demethylation of Foxp3-Tregs-specific demethylated region (Foxp-3-TSDR) was detected by methylation specific PCR (MSP) in order to reflect the cellular stability of CD4+CD25+ Tregs. DNA binding activity of NF-κB signaling pathway was determined by electrophoretic mobility shift assay (EMSA), and activity of NF-κB signaling pathway was determined by Western blotting. RESULTS: Compared with control group, LPS could increase the cellular stability, including an increase in the mRNA and protein expressions of Foxp-3, CTLA-4 and TGF-β1m+ and secretion of IL-10 and sTGF-β1, decrease in the level of apoptosis and increase in the methylation of Foxp-3-TSDR. At the same time, LPS increased DNA binding activity of NF-κB signaling pathway and phosphorylation levels of the major molecules of NF-κB, including inhibitory protein kinaseβ (IKKβ) and p65, suggesting that the mechanism of enhancing cellular stability by LPS was related to the NF-κB signaling pathway. Compared with LPS group, PBS had no effect on cellular stability and NF-κB signaling pathway. However, administration of rSema3A further promoted cellular stability and activated NF-κB signaling pathway. Compared with LPS + PBS + rSema3A group, PDTC inhibited the function of rSema3A to increase cellular stability, as the mRNA and protein expressions of Foxp-3, CTLA-4 and TGF-β1m+ were significantly down-regulated in the LPS + PDTC + rSema3A group [Foxp-3 mRNA (2-ΔΔCt): 8.092±1.117 vs. 18.509±1.068, Foxp-3 protein (relative fluorescence intensity): 1.224±0.033 vs. 1.826±0.181; CTLA-4 mRNA (2-ΔΔCt): 3.254±0.760 vs. 11.840±0.827, CTLA-4 protein (relative fluorescence intensity): 1.305±0.058 vs. 1.842±0.111; TGF-β1m+ mRNA (2-ΔΔCt): 3.589±1.180 vs. 8.509±0.472, TGF-β1m+ protein (relative fluorescence intensity): 1.319±0.033 vs. 1.822±0.063, all P < 0.01], the secretion of IL-10 and sTGF-β1 were significantly decreased [IL-10 (ng/L): 445.33±54.08 vs. 992.67±83.10, sTGF-β1 (ng/L): 1 116.67±65.25 vs. 1 494.67±94.45, both P < 0.01], the apoptosis was significantly increased (fluorescence intensity: 0.398±0.031 vs. 0.268±0.046, P < 0.01), the methylation of Foxp-3-TSDR was significantly decreased (grey value: 0.467±0.048 vs. 1.780±0.119, P < 0.01), the DNA binding activity of NF-κB signaling pathway was significantly inhibited (grey value: 1.23±0.02 vs. 3.95±0.06, P < 0.01), and the phosphorylation levels of IKKβ and p65 were significantly decreased [p-IKKβ (p-IKKβ/IKKβ): 0.97±0.07 vs. 1.97±0.04, p-p65 (p-p65/p65): 0.95±0.08 vs. 1.93±0.06, both P < 0.01]. CONCLUSIONS: LPS increases the cellular stability of CD4+CD25+ Tregs through the NF-κB signaling pathway, and Sema3A further increases the cellular stability of CD4+CD25+ Tregs, and is related to the NF-κB signaling pathway.
    [Abstract] [Full Text] [Related] [New Search]